FDA reform: is it enough? After a critical IOM report, agency moves to work harder on drug safety, but Congress presses ahead with its own changes.
The FDA has outlined its plan to use new technology, improve communication and invigorate its management to better ensure the safety of drugs and medical devices. It's a direction welcomed by providers. "We need to restore balance, because the information we're getting on drugs is too one-sided and pitched toward benefits," says Gordon Schiff, left, of John H. Stroger Jr. Hospital of Cook County.
Robeznieks
Andis
A
D018795:Device Approval; D017277:Drug Approval; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D033181:Information Dissemination; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D012449:Safety; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration